Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy van der Meel

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Nature Nanotechnology|April 7, 2020
Nanotechnology for organ-tunable gene editingRoy van der Meel
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2018
Translating nanomedicines: Thinking beyond materials? A young investigator's reply to 'The Novelty Bubble'Dominik Witzigmann, Sjoerd Hak, Roy van der Meel
Cell Systems|August 19, 2021
What does the success of mRNA vaccines tell us about the future of biological therapeutics?Katalin Karikó, Kathryn Whitehead, Roy van der Meel
Expert Opinion on Drug Delivery|November 18, 2016
Cancer nanomedicines: oversold or underappreciated?Roy van der Meel, Twan Lammers, Wim E Hennink
Nanomedicine (London, England)|September 19, 2023
Nanomedicine approaches for <i>in vivo</i> cancer immunotherapyStijn Rj Hofstraat, Tom Anbergen, Roy van der Meel
Theranostics|July 21, 2020
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacyYang Shi, Roy van der Meel, Xiaoyuan Chen, et al.
Nucleic Acid Therapeutics|April 24, 2018
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical UtilityJayesh A Kulkarni, Pieter R Cullis, Roy van der Meel
Nature Materials|July 2, 2024
Lipid discovery for mRNA delivery guided by machine learningRoy van der Meel, Francesca Grisoni, Willem J M Mulder
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 8, 2025
Engineering Lipid Nanoparticles for mRNA ImmunotherapyRobby Zwolsman, Youssef B Darwish, Ewelina Kluza, et al.
Accounts of Chemical Research|August 10, 2019
Lipid Nanoparticle Technology for Clinical Translation of siRNA TherapeuticsJayesh A Kulkarni, Dominik Witzigmann, Sam Chen, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Nature Nanotechnology|April 7, 2020
Nanotechnology for organ-tunable gene editingRoy van der Meel
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2018
Translating nanomedicines: Thinking beyond materials? A young investigator's reply to 'The Novelty Bubble'Dominik Witzigmann, Sjoerd Hak, Roy van der Meel
Cell Systems|August 19, 2021
What does the success of mRNA vaccines tell us about the future of biological therapeutics?Katalin Karikó, Kathryn Whitehead, Roy van der Meel
Expert Opinion on Drug Delivery|November 18, 2016
Cancer nanomedicines: oversold or underappreciated?Roy van der Meel, Twan Lammers, Wim E Hennink
Nanomedicine (London, England)|September 19, 2023
Nanomedicine approaches for <i>in vivo</i> cancer immunotherapyStijn Rj Hofstraat, Tom Anbergen, Roy van der Meel
Theranostics|July 21, 2020
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacyYang Shi, Roy van der Meel, Xiaoyuan Chen, et al.
Nucleic Acid Therapeutics|April 24, 2018
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical UtilityJayesh A Kulkarni, Pieter R Cullis, Roy van der Meel
Nature Materials|July 2, 2024
Lipid discovery for mRNA delivery guided by machine learningRoy van der Meel, Francesca Grisoni, Willem J M Mulder
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 8, 2025
Engineering Lipid Nanoparticles for mRNA ImmunotherapyRobby Zwolsman, Youssef B Darwish, Ewelina Kluza, et al.
Accounts of Chemical Research|August 10, 2019
Lipid Nanoparticle Technology for Clinical Translation of siRNA TherapeuticsJayesh A Kulkarni, Dominik Witzigmann, Sam Chen, et al.
Pageof 6